Obstructive and Restrictive Lung Function Measures and CKD: National Health and Nutrition Examination Survey (NHANES) 2007-2012

American Journal of Kidney Diseases

Volumn 68, Issue 3, 2016, Pages 414-421

  Navaneethan, Sankar D ^a,b   Mandayam, Sreedhar ^a   Arrigain, Susana ^c   Rahman, Mahboob ^d   Winkelmayer, Wolfgang C ^a   Schold, Jesse D ^c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

albuminuria; chronic kidney disease (CKD); estimated glomerular filtration rate (eGFR); lower respiratory disease; Lung disease; mortality; National Health and Nutrition Examination Survey (NHANES); obstructive lung function; renal function; restrictive lung function; spirometry; urine albumin creatinine ratio (UACR)

Indexed keywords

ALBUMIN; CREATININE;

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEALTH SURVEY; HUMAN; KIDNEY FUNCTION; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; OBSTRUCTIVE LUNG FUNCTION; PREVALENCE; PROPORTIONAL HAZARDS MODEL; RESTRICTIVE LUNG FUNCTION; SPIROMETRY; UNITED STATES; AGED; CHRONIC KIDNEY FAILURE; COMPLICATION; LUNG; LUNG FUNCTION TEST; NUTRITION; PATHOPHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

ADULT; AGED; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; NUTRITION SURVEYS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RENAL INSUFFICIENCY, CHRONIC; RESPIRATORY FUNCTION TESTS;

EID: 84964661989     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2016.03.415     Document Type: Article

References (34)

1. 1 Xu, J.Q., Murphy, S.L., Kochanek, K.D., Bastian, B.A., Deaths: final data for 2013. Natl Vital Stat Rep, 64(2), 2016.
2. 2 Ford, E.S., Mannino, D.M., Wheaton, A.G., Giles, W.H., Presley-Cantrell, L., Croft, J.B., Trends in the prevalence of obstructive and restrictive lung function among adults in the United States: findings from the National Health and Nutrition Examination Surveys from 1988-1994 to 2007-2010. Chest 143:5 (2013), 1395–1406.
3. 3 Afonso, A.S., Verhamme, K.M., Sturkenboom, M.C., Brusselle, G.G., COPD in the general population: prevalence, incidence and survival. Respir Med 105:12 (2011), 1872–1884.
4. 4 Mannino, D.M., Buist, A.S., Global burden of COPD: risk factors, prevalence, and future trends. Lancet 370:9589 (2007), 765–773.
5. 5 Mannino, D.M., Higuchi, K., Yu, T.C., et al. Economic burden of COPD in the presence of comorbidities. Chest 148:1 (2015), 138–150.
6. 6 Ford, E.S., Hospital discharges, readmissions, and ED visits for COPD or bronchiectasis among US adults: findings from the nationwide inpatient sample 2001-2012 and nationwide emergency department sample 2006-2011. Chest 147:4 (2015), 989–998.
7. 7 Ford, E.S., Murphy, L.B., Khavjou, O., Giles, W.H., Holt, J.B., Croft, J.B., Total and state-specific medical and absenteeism costs of COPD among adults aged >/= 18 years in the United States for 2010 and projections through 2020. Chest 147:1 (2015), 31–45.
8. 8 Wheaton, A.G., Ford, E.S., Thompson, W.W., Greenlund, K.J., Presley-Cantrell, L.R., Croft, J.B., Pulmonary function, chronic respiratory symptoms, and health-related quality of life among adults in the United States–National Health and Nutrition Examination Survey 2007-2010. BMC Public Health, 13, 2013, 854.
9. 9 Coresh, J., Selvin, E., Stevens, L.A., et al. Prevalence of chronic kidney disease in the United States. JAMA 298:17 (2007), 2038–2047.
10. 10 Muntner, P., He, J., Astor, B.C., Folsom, A.R., Coresh, J., Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the Atherosclerosis Risk in Communities Study. J Am Soc Nephrol 16:2 (2005), 529–538.
11. 11 Go, A.S., Chertow, G.M., Fan, D., McCulloch, C.E., Hsu, C.Y., Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351:13 (2004), 1296–1305.
12. 12 Navaneethan, S.D., Schold, J.D., Arrigain, S., Jolly, S.E., Nally, J.V. Jr., Cause-specific deaths in non-dialysis-dependent CKD. J Am Soc Nephrol 26:10 (2015), 2512–2520.
13. 13 Incalzi, R.A., Corsonello, A., Pedone, C., et al. Chronic renal failure: a neglected comorbidity of COPD. Chest 137:4 (2010), 831–837.
14. 14 van Gestel, Y.R., Chonchol, M., Hoeks, S.E., et al. Association between chronic obstructive pulmonary disease and chronic kidney disease in vascular surgery patients. Nephrol Dial Transplant 24:9 (2009), 2763–2767.
15. 15 Levey, A.S., Stevens, L.A., Schmid, C.H., et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 150:9 (2009), 604–612.
16. 16 Center for Disease Control and Prevention. Spirometry codebook. http://wwwn.cdc.gov/nchs/nhanes/2011-2012/SPX_G.htm. Accessed April 21, 2016.
17. 17 Rabe, K.F., Hurd, S., Anzueto, A., et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176:6 (2007), 532–555.
18. 18 Tilert, T., Dillon, C., Paulose-Ram, R., Hnizdo, E., Doney, B., Estimating the U.S. prevalence of chronic obstructive pulmonary disease using pre- and post-bronchodilator spirometry: the National Health and Nutrition Examination Survey (NHANES) 2007-2010. Respir Res, 14, 2013, 103.
19. 19 Baty, F., Putora, P.M., Isenring, B., Blum, T., Brutsche, M., Comorbidities and burden of COPD: a population based case-control study. PLoS One, 8(5), 2013, e63285.
20. 20 Mapel, D.W., Marton, J.P., Prevalence of renal and hepatobiliary disease, laboratory abnormalities, and potentially toxic medication exposures among persons with COPD. Int J Chron Obstruct Pulmon Dis 8 (2013), 127–134.
21. 21 Bulcun, E., Ekici, M., Ekici, A., Kisa, U., Microalbuminuria in chronic obstructive pulmonary disease. COPD 10:2 (2013), 186–192.
22. 22 Romundstad, S., Naustdal, T., Romundstad, P.R., Sorger, H., Langhammer, A., COPD and microalbuminuria: a 12-year follow-up study. Eur Respir J 43:4 (2014), 1042–1050.
23. 23 Casanova, C., de Torres, J.P., Navarro, J., et al. Microalbuminuria and hypoxemia in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 182:8 (2010), 1004–1010.
24. 24 Hurtado, A., Escudero, E., Pando, J., Sharma, S., Johnson, R.J., Cardiovascular and renal effects of chronic exposure to high altitude. Nephrol Dial Transplant 27:suppl 4 (2012), iv11–iv16.
25. 25 Bhavani, S., Tsai, C.L., Perusich, S., et al. Clinical and immunological factors in emphysema progression: 5-year prospective LES-COPD study. Am J Respir Crit Care Med 192:10 (2015), 1171–1178.
26. 26 Mannino, D.M., Ford, E.S., Redd, S.C., Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination. Am J Med 114:9 (2003), 758–762.
27. 27 Yoon, J.H., Won, J.U., Ahn, Y.S., Roh, J., Poor lung function has inverse relationship with microalbuminuria, an early surrogate marker of kidney damage and atherosclerosis: The 5th Korea National Health and Nutrition Examination Survey. PLoS One, 9(4), 2014, e94125.
28. 28 Marino F, Martorano C, Tripepi R, et al. Subclinical pulmonary congestion is prevalent in nephrotic syndrome [published online ahead of print October 7, 2015]. Kidney Int. http://dx.doi.org/10.1038/ki.2015.279.
29. 29 Chronic Kidney Disease Prognosis Consortium, Matsushita, K., van der Velde, M., Astor, B.C., et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 375:9731 (2010), 2073–2081.
30. 30 Ford, E.S., Urinary albumin-creatinine ratio, estimated glomerular filtration rate, and all-cause mortality among US adults with obstructive lung function. Chest 147:1 (2015), 56–67.
31. 31 Johnston, A.K., Mannino, D.M., Hagan, G.W., Davis, K.J., Kiri, V.A., Relationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-aged cohort. Thorax 63:7 (2008), 599–605.
32. 32 Navaneethan, S.D., Roy, J., Tao, K., et al. Prevalence, predictors, and outcomes of pulmonary hypertension in CKD. J Am Soc Nephrol 27:3 (2016), 877–886.
33. 33 Navaneethan, S.D., Schold, J.D., Huang, H., et al. Mortality outcomes of patients with chronic kidney disease and chronic obstructive pulmonary disease. Am J Nephrol 43:1 (2016), 39–46.
34. 34 Vaz Fragoso, C.A., McAvay, G., Van Ness, P.H., et al. Phenotype of normal spirometry in an aging population. Am J Respir Crit Care Med 192:7 (2015), 817–825.